Insmed Wins FDA Priority Review for ARIKAYCE sNDA
Bridgewater, New Jersey, U.S., September 21, 2026 Insmed has announced that the U.S. Food and Drug Administration (FDA) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Bridgewater, New Jersey, U.S., September 21, 2026 Insmed has announced that the U.S. Food and Drug Administration (FDA) has...
Bridgewater, New Jersey, USA, September 3, 2026 Insmed Incorporated announced that five abstracts from its respiratory portfolio have been...
Garden City, N.Y. – August 31, 2026 Beyond Air announced that the U.S. Food and Drug Administration has granted...
